Development of a dual luciferase activity and fluorescamine protein assay adapted to a 384 micro-well plate format: Reducing variability in human luciferase transactivation cell lines aimed at endocrine active substances
Toxicology in Vitro
Links
- More information: Publisher Index Page (via DOI)
- Data Release: USGS data release - Development of a dual luciferase-fluorescamine assay adapted to a 384 micro-well plate format-Data
- Open Access Version: Publisher Index Page
- Download citation as: RIS | Dublin Core
Abstract
There is a need to adapt cell bioassays to 384-well and 1536-well formats instead of the traditional 96-well format as high-throughput screening (HTS) demands increase. However, the sensitivity and performance of the bioassay must be re-verified in these higher micro-well plates, and verification of cell health must also be HT (high-throughput). We have adapted two commonly used human breast luciferase transactivation cell bioassays, the recently re-named estrogen agonist/antagonist screening VM7Luc4E2 cell bioassay (previously designated BG1Luc4E2) and the androgen/glucocorticoid screening MDA-kb2 cell bioassay, to 384-well formats for HTS of endocrine-active substances (EASs). This cost-saving adaptation includes a fast, accurate, and easy measurement of protein amount in each well via the fluorescamine assay with which to normalize luciferase activity of cell lysates without requiring any transfer of the cell lysates. Here we demonstrate that by accounting for protein amount in the cell lysates, antagonistic agents can easily be distinguished from cytotoxic agents in the MDA-kb2 and VM7Luc4E2 cell bioassays. Additionally, we demonstrate via the fluorescamine assay improved interpretation of luciferase activity in wells along the edge of the plate (the so-called “edge effect”), thereby increasing usable wells to the entire plate, not just interior wells.
Suggested Citation
Brennan, J., Tillitt, D.E., 2018, Development of a dual luciferase activity and fluorescamine protein assay adapted to a 384 micro-well plate format: Reducing variability in human luciferase transactivation cell lines aimed at endocrine active substances: Toxicology in Vitro, v. 47, p. 18-25, https://doi.org/10.1016/j.tiv.2017.10.030.
| Publication type | Article |
|---|---|
| Publication Subtype | Journal Article |
| Title | Development of a dual luciferase activity and fluorescamine protein assay adapted to a 384 micro-well plate format: Reducing variability in human luciferase transactivation cell lines aimed at endocrine active substances |
| Series title | Toxicology in Vitro |
| DOI | 10.1016/j.tiv.2017.10.030 |
| Volume | 47 |
| Year Published | 2018 |
| Language | English |
| Publisher | Elsevier |
| Contributing office(s) | Columbia Environmental Research Center |
| Description | 8 p. |
| First page | 18 |
| Last page | 25 |